These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 9264539)

  • 1. Synthesis and kinetic studies of diphenyl 1-(N-peptidylamino)alkanephosphonate esters and their biotinylated derivatives as inhibitors of serine proteases and probes for lymphocyte granzymes.
    Abuelyaman AS; Jackson DS; Hudig D; Woodard SL; Powers JC
    Arch Biochem Biophys; 1997 Aug; 344(2):271-80. PubMed ID: 9264539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorescent derivatives of diphenyl [1-(N-peptidylamino)alkyl]phosphonate esters: synthesis and use in the inhibition and cellular localization of serine proteases.
    Abuelyaman AS; Hudig D; Woodard SL; Powers JC
    Bioconjug Chem; 1994; 5(5):400-5. PubMed ID: 7849068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chymase-directed serine protease inhibitor that reacts with a single 30-kDa granzyme and blocks NK-mediated cytotoxicity.
    Woodard SL; Jackson DS; Abuelyaman AS; Powers JC; Winkler U; Hudig D
    J Immunol; 1994 Dec; 153(11):5016-25. PubMed ID: 7963562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification and characterization of lymphocyte chymase I, a granzyme implicated in perforin-mediated lysis.
    Woodard SL; Fraser SA; Winkler U; Jackson DS; Kam CM; Powers JC; Hudig D
    J Immunol; 1998 May; 160(10):4988-93. PubMed ID: 9590247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Irreversible inhibition of serine proteases by peptide derivatives of (alpha-aminoalkyl)phosphonate diphenyl esters.
    Oleksyszyn J; Powers JC
    Biochemistry; 1991 Jan; 30(2):485-93. PubMed ID: 1988040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and evaluation of diphenyl phosphonate esters as inhibitors of the trypsin-like granzymes A and K and mast cell tryptase.
    Jackson DS; Fraser SA; Ni LM; Kam CM; Winkler U; Johnson DA; Froelich CJ; Hudig D; Powers JC
    J Med Chem; 1998 Jun; 41(13):2289-301. PubMed ID: 9632362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Granzymes (lymphocyte serine proteases): characterization with natural and synthetic substrates and inhibitors.
    Kam CM; Hudig D; Powers JC
    Biochim Biophys Acta; 2000 Mar; 1477(1-2):307-23. PubMed ID: 10708866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulfonyl fluoride serine protease inhibitors inactivate RNK-16 lymphocyte granule proteases and reduce lysis by granule extracts and perforin.
    Ewoldt GR; Winkler U; Powers JC; Hudig D
    Mol Immunol; 1992 Jun; 29(6):713-21. PubMed ID: 1603092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective chemical functional probes of granzymes A and B reveal granzyme B is a major effector of natural killer cell-mediated lysis of target cells.
    Mahrus S; Craik CS
    Chem Biol; 2005 May; 12(5):567-77. PubMed ID: 15911377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The function of lymphocyte proteases. Inhibition and restoration of granule-mediated lysis with isocoumarin serine protease inhibitors.
    Hudig D; Allison NJ; Pickett TM; Winkler U; Kam CM; Powers JC
    J Immunol; 1991 Aug; 147(4):1360-8. PubMed ID: 1869829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human granzyme B is essential for DNA fragmentation of susceptible target cells.
    Su B; Bochan MR; Hanna WL; Froelich CJ; Brahmi Z
    Eur J Immunol; 1994 Sep; 24(9):2073-80. PubMed ID: 8088328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel substrate-binding pocket interaction restricts the specificity of the human NK cell-specific serine protease, Met-ase-1.
    Smyth MJ; O'Connor MD; Trapani JA; Kershaw MH; Brinkworth RI
    J Immunol; 1996 Jun; 156(11):4174-81. PubMed ID: 8666785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The human cytotoxic T cell granule serine protease granzyme H has chymotrypsin-like (chymase) activity and is taken up into cytoplasmic vesicles reminiscent of granzyme B-containing endosomes.
    Edwards KM; Kam CM; Powers JC; Trapani JA
    J Biol Chem; 1999 Oct; 274(43):30468-73. PubMed ID: 10521426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization, application and potential uses of biotin-tagged inhibitors for lymphocyte serine proteases (granzymes).
    Winkler U; Allison NJ; Woodard SL; Gault RA; Ewoldt GR; Kam CM; Abuelyaman A; Powers JC; Hudig D
    Mol Immunol; 1996; 33(7-8):615-23. PubMed ID: 8760273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human and murine cytotoxic T lymphocyte serine proteases: subsite mapping with peptide thioester substrates and inhibition of enzyme activity and cytolysis by isocoumarins.
    Odake S; Kam CM; Narasimhan L; Poe M; Blake JT; Krahenbuhl O; Tschopp J; Powers JC
    Biochemistry; 1991 Feb; 30(8):2217-27. PubMed ID: 1998680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic inhibition of human cell-mediated cytotoxicity by complement component antisera indicates that target cell lysis may result from an enzymatic cascade involving granzymes and perforin.
    Brahmi Z; Csipo I; Bochan MR; Su B; Montel AH; Morse PA
    Nat Immun; 1995 Sep; 14(5-6):271-85. PubMed ID: 8933821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of antigenic peptides by lymphocyte granule serine proteases (granzymes).
    Carter CR; Sayers TJ; Wiltrout RH; Turcovski-Corrales SM; Taub DD
    Cell Immunol; 1996 Sep; 172(2):235-45. PubMed ID: 8964086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Asymmetric preference of serine proteases toward phosphonate and phosphinate esters.
    Walker B; Wharry S; Hamilton RJ; Martin SL; Healy A; Walker BJ
    Biochem Biophys Res Commun; 2000 Oct; 276(3):1235-9. PubMed ID: 11027616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Irreversible inhibition of serine proteases by peptidyl derivatives of alpha-aminoalkylphosphonate diphenyl esters.
    Oleksyszyn J; Powers JC
    Biochem Biophys Res Commun; 1989 May; 161(1):143-9. PubMed ID: 2730652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 2.2 A crystal structure of human chymase in complex with succinyl-Ala-Ala-Pro-Phe-chloromethylketone: structural explanation for its dipeptidyl carboxypeptidase specificity.
    Pereira PJ; Wang ZM; Rubin H; Huber R; Bode W; Schechter NM; Strobl S
    J Mol Biol; 1999 Feb; 286(1):163-73. PubMed ID: 9931257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.